Survivin: A target from brain cancer to neurodegenerative disease

References

• Agell N, Bachs O, Rocamora N and Villalonga P. 2002. Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin. Cell Signal 14:649–654.
   PubMed Web of Science ®Google Scholar
• Altieri DC. 2003. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46–54.
   PubMed Web of Science ®Google Scholar
• Altieri DC. 2006. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 18:609–615.
   PubMed Web of Science ®Google Scholar
• Altieri DC. 2008. Opinion – Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8:61–70.
   PubMed Web of Science ®Google Scholar
• Altura RA, Olshefski RS, Jiang Y and Boue DR. 2003. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Brit J Cancer 89:1743–1749.
   PubMed Web of Science ®Google Scholar
• Alubaidi MR, Hollyfield JG, Overbeek PA and Baehr W. 1992. Photoreceptor degeneration induced by the expression of simian virus-40 large tumor-antigen in the retina of transgenic mice. Proc Natl Acad Sci USA 89:1194–1198.
   PubMedGoogle Scholar
• Ambrosini G, Adida C and Altieri DC. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921.
   PubMed Web of Science ®Google Scholar
• Amiri S, Movahedin M, Mowla SJ, Hajebrahimi Z and Tavallaei M. 2009. Differential gene expression and alternative splicing of survivin following mouse sciatic nerve injury. Spinal Cord 47:739–744.
   PubMedGoogle Scholar
• Aoki K, Zubkov AY, Ross IB and Zhang JH. 2002. Therapeutic effect of caspase inhibitors in the prevention of apoptosis and reversal of chronic cerebral vasospasm. J Clin Neurosci 9:672–677.
   PubMed Web of Science ®Google Scholar
• Arendt T, Holzer M and Gartner U. 1998. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer’s disease. J Neural Transm 105:949–960.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420–430.
   PubMed Web of Science ®Google Scholar
• Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T and Inuzuka M. 2004. Identification of a novel splice variant of the human anti-apoptosis gene survivin. Biochem Biophys Res Comm 314:902–907.
   PubMed Web of Science ®Google Scholar
• Bao RD, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA and Hamilton TC. 2002. Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst 94:522–528.
   PubMedGoogle Scholar
• Baratchi S, Kanwar RK, Khoshmanesh K, Vasu P, Ashok C, Hittu M, Parratt A, Krishnakumar S, Sun XY, Sahoo SK and Kanwar JR. 2009. Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases. Curr Nanosci 5:15–25.
   Web of Science ®Google Scholar
• Baratchi S, Kanwar RK, Cheung CHA and Kanwar JR. 2010. Proliferative and protective effects of SurR9-C84A on differentiated neural cells. J Neuroimmunol 227:120–32.
   PubMed Web of Science ®Google Scholar
• Berman SB, Chen YB, Qi B, McCaffery JM, Rucker EB, Goebbels S, Nave KA, Arnold BA, Jonas EA, Pineda FJ and Hardwick JM. 2009. Bcl-x(L) increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol 184:707–719.
   PubMed Web of Science ®Google Scholar
• Boman B, Kopellovich L, Siracusa LD, Zhang T, Henderson K, Cofer Z, Buchberg AM, Fields JZ and Otevrel T. 2009. A Tcf4-GFP reporter mouse model for monitoring effects of apc mutations during intestinal tumorigenesis. Mol Carcinogen 48:821–831.
   PubMedGoogle Scholar
• Bradley EW, Ruan MM and Oursler MJ. 2008. PAK1 is a novel MEK-independent raf target controlling expression of the IAP survivin in M-CSF-mediated osteoclast survival. J Cell Physiol 217:752–758.
   Google Scholar
• Bradley WD and Koleske AJ. 2009. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts. J Cell Sci 122:3441–3454.
   PubMed Web of Science ®Google Scholar
• Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL and Tuomanen EI. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 5:298–302.
   PubMed Web of Science ®Google Scholar
• Brenner C and Kroemer G. 2000. Apoptosis – mitochondria – the death signal integrators. Science 289:1150–1151.
   PubMed Web of Science ®Google Scholar
• Bulat N and Widmann C. 2009. Caspase substrates and neurodegenerative diseases. Brain Res Bull 80:251–267.
   PubMedGoogle Scholar
• Burns KA, Ayoub AE, Breunig JJ, Adhami F, WengWL Colbert, MC, Rakic P and Kuan CY. 2007. Nestin-CreER mice reveal DNA synthesis by nonapoptotic neurons following cerebral ischemia-hypoxia. Cereb Cortex 17:2585–2592.
   PubMedGoogle Scholar
• Burstein E and Duckett CS. 2003. Dying for NF-kappa B? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol 15:732–737.
   PubMed Web of Science ®Google Scholar
• Busser J, Geldmacher DS and Herrup K. 1998. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain. J Neurosci 18:2801–2807.
   PubMed Web of Science ®Google Scholar
• Caldas H, Honsey LE and Altura RA. 2005a. Survivin 2 alpha: a novel survivin splice variant expressed in human malignancies. Mol Cancer 4:11.
   PubMed Web of Science ®Google Scholar
• Caldas H, Jiang YY, Holloway MP, Fangusaro J, Mahotka C, Conway EM and Altura RA. 2005b. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24:1994–2007.
   PubMed Web of Science ®Google Scholar
• Cao LH, Yan XM, Wu YH, Hu HR, Li Q, Zhou T, Jiang SM and Yu L. 2006. Survivin mutant (Surv-DD70, 71AA) disrupts the interaction of Survivin with Aurora B and causes multinucleation in HeLa cells. Biochem Biophys Res Comm 346:400–407.
   PubMed Web of Science ®Google Scholar
• Carmena M. 2008. Cytokinesis: the final stop for the chromosomal passengers. Biochem Soc Trans 36:367–370.
   Google Scholar
• Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA, Robe P, Nestler U, Song QH and Loeffler J. 2004. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23:7494–7506.
   PubMed Web of Science ®Google Scholar
• Charriaut-Marlangue C. 2004. Apoptosis: A target for neuroprotection. Therapie 59:185–190.
   PubMedGoogle Scholar
• Chen CL, Cen L, Kohout J, Hutzen B, Chan C, Hsieh FC, Loy A, Huang V, Cheng G and Lin J. 2008. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer 7:78.
   PubMedGoogle Scholar
• Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC and Ng SC. 2000. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2:235–241.
   PubMed Web of Science ®Google Scholar
• Chen JS, Liu JC, Shen L, Rau KM, Kuo HP, Li YM, Shi D, Lee YC, Chang KJ and Hung MC. 2004. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther 11:740–747.
   PubMed Web of Science ®Google Scholar
• Cheung CHA, Kanwar J and Krissansen GW. 2006. A cell-permeable dominant-negative Survivin protein as a tool to understand how Survivin maintains tumour cell survival. EJC Suppl 4:488.
   Google Scholar
• Cheung CHA, Chen HH, Cheng LT, Lyu KW, Kanwar JR and Chang JY. 2010. Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells. Mol Cancer. 9:77.
   PubMedGoogle Scholar
• Christie LA, Su JH, Tu CH, Dick MC, Zhou J and Cotman CW. 2007. Differential regulation of inhibitors of apoptosis proteins in Alzheimer’s disease brains. Neurobiol Dis 26:165–173.
   PubMedGoogle Scholar
• Christofferson DE and Yuan J. 2010. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22:263–268.
   PubMed Web of Science ®Google Scholar
• Ciesielski MJ, Apfel L, Barone TA, Castro CA, Weiss TC and Fenstermaker RA. 2006. Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas. Cancer Immunol Immunother 55:1491–1503.
   PubMed Web of Science ®Google Scholar
• Ciesielski MJ, Ahluwalia MS, Munich SA, Orton M, Barone T, Chanan-Khan A and Fenstermaker RA. 2010. Antitumor cytotoxic T-cell response induced by a survivin peptide mimic. Cancer Immunol Immunother 59:1211–1221.
   PubMed Web of Science ®Google Scholar
• Citron BA, Arnold PM, Haynes NG, Ameenuddin S, Farooque M, Santacruz K and Festoff BW. 2008. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury. Spine 33:2269–2277.
   PubMed Web of Science ®Google Scholar
• Colak A, Karaoglan A, Barut S, Kokturk S, Akyildiz AI and Tasyurekli M. 2005. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg – Spine 2:327–334.
   PubMed Web of Science ®Google Scholar
• Colnaghi R, Connell CM, Barrett RMA and Wheatley SP. 2006. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 281:33450–33456.
   PubMed Web of Science ®Google Scholar
• Delvaeye M, De Vriese A, Zwerts F, Betz I, Moons M, Autiero M and Conway EM. 2009. Role of the 2 zebrafish survivin genes in vasculo-angiogenesis, neurogenesis, cardiogenesis and hematopoiesis. BMC Dev Biol 9:25.
   PubMedGoogle Scholar
• Demir O, Singh S, Klimaschewski L and Kurnaz IA. 2009. From birth till death: neurogenesis, cell cycle, and neurodegeneration. Anat Rec 292:1953–1961.
   Google Scholar
• Dence CS, Sun X, Mach RH and Welch MJ. 2005. [C-11]-methylated LY2181308, An antisense oligonucleotide to survivin: radiochemical synthesis and preliminary rodent biodistribution studies. J Labelled Compd Rad 48:S161–S161.
   Google Scholar
• Dickson MA, Shah, M.A, Rathkopf D, Tse A, Carvajal RD, Wu N, Lefkowitz RA, Gonen M, Cane LM, Dials HJ, and Schwartz GK. 2010. A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol. Cancer Chemother Pharmacol published online DOI 10.1007/s00280-010-1269-1.
   PubMedGoogle Scholar
• Dietz GPH, Dietz B and Bahr M. 2007. Bcl-X-L protects cerebellar granule neurons against the late phase, but not against the early phase of glutamate-induced cell death. Brain Res 1164:136–141.
   PubMedGoogle Scholar
• Dohi T, Xia F and Altieri DC. 2007. Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell 27:17–28.
   PubMed Web of Science ®Google Scholar
• Donnini S, Solito R, Monti M, Balduini W, Carloni S, Cimino M, Bampton ETW, Pinon LGP, Nicotera P, Thorpe PE and Ziche M. 2009. Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4. Cell Cycle 8:1271–1278.
   PubMed Web of Science ®Google Scholar
• Dziennis S and Alkayed NJ. 2008. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 19:341–361.
   PubMed Web of Science ®Google Scholar
• Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C, Mann W, Kovacs AF and Stauber RH. 2007. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker. J Pathol 211:532–540.
   PubMed Web of Science ®Google Scholar
• Esteve PO, Chin HG and Pradhan S. 2005. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci USA 102:1000–1005.
   PubMed Web of Science ®Google Scholar
• Eyers P. 2009. Survivin(g) phosphorylation? Survivin phosphorylation, mitosis and apoptosis. Cell Cycle 8:183–184.
   PubMed Web of Science ®Google Scholar
• Farkas LM and Huttner WB. 2008. The cell biology of neural stem and progenitor cells and its significance for their proliferation versus differentiation during mammalian brain development. Curr Opin Cell Biol 20:707–715.
   PubMed Web of Science ®Google Scholar
• Feddersen RM, Ehlenfeldt R, Yunis WS, Clark HB and Orr HT. 1992. Disrupted cerebellar cortical development and progressive degeneration of Purkinje-cells in SV40-T antigen transgenic mice. Neuron 9:955–966.
   PubMedGoogle Scholar
• Fei Q, Zhang HY, Fu LL, Dai XL, Gao BM, Ni M, Ge C, Li JJ, Ding X, Ke YW, Yao XB and Zhu JD. 2008. Experimental cancer gene therapy by multiple anti-survivin hammerhead ribozymes. Acta Bioch Bioph Sin 40:466–477.
   PubMedGoogle Scholar
• Feng YZ, Fratkin JD and Leblanc MH. 2003. Inhibiting caspase-9 after injury reduces hypoxic ischemic neuronal injury in the cortex in the newborn rat. Neurosci Lett 344:201–204.
   PubMed Web of Science ®Google Scholar
• Ferreiro E, Eufrasio A, Pereira C, Oliveira CR and Rego AC. 2007. Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis 12:223–228.
   PubMedGoogle Scholar
• Fest S, Huebener N, Gaedicke G and Lode HN. 2008. A novel survivin minigene DNA vaccine induces an effective anti-neuroblastoma immune response. Eur J Pediat 167:362–362.
   Google Scholar
• Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, Marchisio PC, Sessa WC and Altieri DC. 2003. Regulation of survivin function by Hsp90. Proc Natl Acad Sci USA 100:13791–13796.
   PubMed Web of Science ®Google Scholar
• Friedlander RM. 2003. Mechanisms of disease: Apoptosis and caspases in neurodegenerative diseases. New Engl J Med 348:1365–1375.
   PubMed Web of Science ®Google Scholar
• Friedlander RM, Brown RH, Gagliardini V, Wang J and Yuan JY. 1997. Inhibition of ICE slows ALS in mice. Nature 388:31–31.
   PubMed Web of Science ®Google Scholar
• Gal A, Szilagyi G, Wappler E, Safrany G and Nagy Z. 2008. Bcl-2 or Bcl-XL gene therapy reduces apoptosis and increases plasticity protein GAP-43 in PC12 cells. Brain Res Bull 76:349–353.
   PubMed Web of Science ®Google Scholar
• Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, Greenberg DA and Bredesen DE. 2006. Reversal of Alzheimer’s-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103:7130–7135.
   PubMed Web of Science ®Google Scholar
• Garrity-Moses ME, Teng QS, Krudy C, Yang J, Federici T and Boulis NM. 2006. X-linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system. Neurosurgery 59:172–181.
   PubMedGoogle Scholar
• Gassmann R, Carvalho A, Henzing AJ, Ruchaud S, Hudson DE, Honda R, Nigg EA, Gerloff DL and Earnshaw WC. 2004. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J Cell Biol 166:179–191.
   PubMed Web of Science ®Google Scholar
• Ghosh JC, Dohi T, Raskett CM, Kowalik TF and Altieri DC. 2006. Activated checkpoint kinase 2 provides a survival signal for tumor cells. Cancer Res 66:11576–11579.
   Google Scholar
• Giaccone G, Zatloukal P, Roubec J, Floor K, Musil J, Kuta M, Van Klaveren RJ, Chaudhary S, Gunther, A and Shamsili, S. 2009. Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. J Clin Oncol 27:4481–4486.
   PubMedGoogle Scholar
• Gidday JM. 2006. Cerebral preconditioning and ischaemic tolerance. Nature Rev Neurosci 7:437–448.
   PubMed Web of Science ®Google Scholar
• Gleave ME and Monia BP. 2005. Antisense therapy for cancer. Nat Rev Cancer 5:468–479.
   PubMed Web of Science ®Google Scholar
• Gotz R, Karch C, Digby MR, Troppmair J, Rapp UR and Sendtner M. 2000. The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum Mol Genet 9:2479–2489.
   PubMedGoogle Scholar
• Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA and Jove R. 2006. Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12:11–19.
   PubMed Web of Science ®Google Scholar
• Gualco E, Urbanska K, Perez-Liz G, Sweet T, Peruzzi F, Reiss K and Del Valle L. 2009. IGF-IR dependent expression of Survivin is required for T-Antigen mediated protection from Apoptosis and proliferation of neural progenitors. J Neurovirol 15:P68.
   Google Scholar
• Gyurkocza B, Plescia J, Raskett CM, Garlick DS, Lowry PA, Carter BZ, Andreeff M, Meli M, Colombo G and Altieri DC. 2006. Antileukemic activity of shepherdin and molecular diversity of Hsp90 inhibitors. J Natl Cancer Inst 98:1068–1077.
   PubMedGoogle Scholar
• Hagberg H, Mallard C, Rousset CI and Wang XY. 2009. Apoptotic Mechanisms in the Immature Brain: Involvement of Mitochondria. J Child Neurol 24:1141–1146.
   PubMed Web of Science ®Google Scholar
• Hahn HP, Pang M, He J, Hernandez JD, Yang RY, Li LY, Wang X, Liu FT and Baum LG. 2004. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ 11:1277–1286.
   PubMed Web of Science ®Google Scholar
• Hansen MR, Roehm PC, Xu NY and Green SH. 2007. Overexpression of Bcl-2 or Bcl-xL prevents spiral ganglion neuron death and inhibits neurite growth. Dev Neurobiol 67:316–325.
   PubMed Web of Science ®Google Scholar
• Havran LM, Chong DC, Childers WE, Dollings PJ, Dietrich A, Harrison BL, Marathias V, Tawa G, Aulabaugh A, Cowling R, Kapoor B, Xu WX, Mosyak L, Moy F, Hum WT, Wood A and Robichaud AJ. 2009. 3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3. Bioorg Med Chem 17:7755–7768.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Jikihara I, Yagi T, Fukumura M, Ohashi Y, Ohta Y, Takagi H and Maeda M. 2001. Immunohistochemical investigation of caspase-1 and effect of caspase-1 inhibitor in delayed neuronal death after transient cerebral ischemia. Brain Res 893:113–120.
   PubMedGoogle Scholar
• Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770–776.
   PubMed Web of Science ®Google Scholar
• Herrup K and Yang Y. 2007. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nature Rev Neurosci 8:368–378.
   PubMed Web of Science ®Google Scholar
• Hilmi C, Larribere L, Giuliano S, Bille K, Ortonne JP, Ballotti R and Bertolotto C. 2008. IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin. J Invest Dermatol 128:1499–1505.
   PubMed Web of Science ®Google Scholar
• Hoeglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, Alvarez-Fischer D, Boutillier A-L Degregori, J, Oertel WH, Rakic P, Hirsch EC and Hunot S. 2007. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson’s disease. Proc Natl Acad Sci USA 104:3585–3590.
   PubMedGoogle Scholar
• Honda R, Korner R and Nigg EA. 2003. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol Biol Cell 14:3325–3341.
   PubMed Web of Science ®Google Scholar
• Hong Z, Qin L, Zhen L, Mei YW and Guo YL. 2008. The protection of Bcl-2 overexpression on rat cortical neuronal injury caused by analogous ischemia/reperfusion in vitro. Neurosci Res 62:140–146.
   PubMed Web of Science ®Google Scholar
• Honma I, Kitamura H, Torigoe T, Takahashi A, Tanaka T, Sato E, Hirohashi Y, Masumori N, Tsukamoto T and Sato N. 2009. Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer. Cancer Immunol Immunother 58:1803–1809.
   Google Scholar
• Honore S, Pasquier E and Braguer D. 2005. Understanding microtubule dynamics for improved cancer therapy. Cell Mol Life Sci 62:3039–3056.
   PubMed Web of Science ®Google Scholar
• Inoue S, Davis DP, Drummond JC, Cole DJ and Patel PM. 2006. The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia. Anesth Analg 102:1548–1555.
   PubMed Web of Science ®Google Scholar
• Islam A, Kageyama H, Hashizume K, Kaneko Y and Nakagawara A. 2000. Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Ped Oncol 35:550–553.
   PubMedGoogle Scholar
• Janssens V, Goris J and Van Hoof C. 2005. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 15:34–41.
   PubMedGoogle Scholar
• Jiang LB, Liu XQ, Li B, He XJ, Jin YL, Li LQ, Gao F and Wang NL. 2008. Heat shock proteins and survivin: Relationship and effects on proliferation index of retinoblastoma cells. Histol Histopathol 23:827–831.
   PubMedGoogle Scholar
• Jiang YY, De Bruin A, Caldas H, Fangusaro J, Hayes J, Conway EM, Robinson ML and Altura RA. 2005. Essential role for survivin in early brain development. J Neurosci 25:6962–6970.
   PubMed Web of Science ®Google Scholar
• Jordan J, Cena V and Prehn JHM. 2003. Mitochondrial control of neuron death and its role in neurodegenerative disorders. J Physiol Biochem 59:129–141.
   PubMed Web of Science ®Google Scholar
• Jordan-Sciutto KL, Wang GJ, Murphey-Corb M and Wiley CA. 2002. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. J Neurosci 22:2185–2195.
   PubMed Web of Science ®Google Scholar
• Kaneko N, Kita A, Nakahara T, Nakata M, Koutoku H and Sasamata M. 2010. Tumor regression induced by YM155, a novel, survivin suppressant, in human diffuse large B-cell lymphoma models. J Pharmacol Sci 112:260P–260P.
   Google Scholar
• Kang BH and Altieri DC. 2006. Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J Biol Chem 281:24721–24727.
   PubMed Web of Science ®Google Scholar
• Kanwar JR. 2005. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease. Curr Med Chem 12:2947–2962.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Shen WP, Kanwar RK, Berg RW and Krissansen GW. 2001. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst 93:1541–1552.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Kanwar RK and Krissansen GW. 2004a. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127:1313–1331.
   PubMedGoogle Scholar
• Kanwar JR, Shen WP, Kanwar RK, Sun XY, Berg RW and Krissansen GW. 2004b. Survivin antagonists and antisense HIF-1 alpha stimulate the generation of tumor-specific CTLs: May be beneficial for the treatment of large lymphomas. Cancer Gene Ther 11:853.
   Google Scholar
• Kanwar JR, Kanwar RK, Burrow H and Baratchi S. 2009a. Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders. Curr Med Chem 16:2373–2394.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Mahidhara G and Kanwar RK. 2009b. Recent Advances in Nanoneurology for Drug Delivery to the Brain. Curr Nanosci 5:441–448.
   Web of Science ®Google Scholar
• Kanwar RK, Cheung CHA, Chang JY and Kanwar JR. 2010. Recent Advances in Anti-Survivin Treatments for Cancer. Curr Med Chem 17:1509–1515.
   PubMedGoogle Scholar
• Karaoglan A, Kaya E, Akdemir O, Sagmanligil A, Bilguvar K, Cirakoglu B, Sahan E, Erdogan N, Barut S and Colak A. 2008. Neuroprotective effects of Ac.YVAD.cmk on experimental spinal cord injury in rats. Surg Neurol 69:561–567.
   PubMedGoogle Scholar
• Khanna N, Thomas G, Stern J and Frazer N. 2006. Effects of EM-1421, a novel transcription inhibitor, on cervical intraepithelial neoplasia: Results of a pilot phase I/II study. EJC Suppl 4:489.
   Google Scholar
• Kim CH, Woo SJ, Park JS, Kim HS, Park MY, Park SD, Hong YK and Kim TG. 2007. Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma. Immunology 122:615–622.
   PubMed Web of Science ®Google Scholar
• Kim S, Kang JH, Qiao JB, Thomas RP, Evers BM and Chung DH. 2004. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. J Ped Surg 39:516–521.
   PubMed Web of Science ®Google Scholar
• Kita A, Nakahara T, Yamanaka K, Nakata M, Kaneko N, Koutoku H and Sasamata M. 2009. YM155: A small molecule survivin suppressant with potent antitumor effect in human breast cancer models. Cancer Res 69:692S–693S.
   Google Scholar
• Knauer SK, Bier C, Habtemichael N and Stauber RH. 2006. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 7:1259–1265.
   PubMed Web of Science ®Google Scholar
• Knauer SK, Bier C, Schlag P, Fritzmann J, Dietmaier W, Rodel F, Klein-Hitpass L, Kovacs AF, Doring C, Hansmann ML, Hofmann WK, Kunkel M, Brochhausen C, Engels K, Lippert BM, Mann W and Stauber RH. 2007. The survivin isoform Survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 6:1502–1509.
   PubMedGoogle Scholar
• Knoblach SM, Alroy DA, Nikolaeva M, Cernak I, Stoica BA and Faden AI. 2004. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab 24:1119–1132.
   PubMedGoogle Scholar
• Krepela E, Dankova P, Moravcikova E, Krepelova A, Prochazka J, Cermak J, Schutzner J, Zatloukal P and Benkova K. 2009. Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Oncol 35:1449–1462.
   PubMed Web of Science ®Google Scholar
• Kroemer G. 2001. Mitochondrial control of apoptosis. B Acad Nat Med Paris 185:1135–1143.
   PubMed Web of Science ®Google Scholar
• Kunigal S, Lakka SS, Sodadasu PK, Estes N and Rao JS. 2009. Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer. Int J Oncol 34:1209–1220.
   PubMed Web of Science ®Google Scholar
• Lang SA, Schachtschneider P, Moser C, Mori A, Hackl C, Gaumann A, Batt D, Schlitt HJ, Geissler EK and Stoeltzing O. 2008. Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Mol Cancer Therapeut 7:3509–3518.
   PubMed Web of Science ®Google Scholar
• Lanza IR and Nair KS. 2010. Mitochondrial function as a determinant of life span. Pflug Arch Eur J Phy 459:277–289.
   PubMed Web of Science ®Google Scholar
• LeBlanc HN and Ashkenazi A. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66–75.
   PubMed Web of Science ®Google Scholar
• Lee SI, Kim BG, Hwang DH, Kim HM and Kim SU. 2009. Overexpression of Bcl-X-L in human neural stem cells promotes graft survival and functional recovery following transplantation in spinal cord injury. J Neurosci Res 87:3186–3197.
   PubMed Web of Science ®Google Scholar
• Lens SMA, Rodriguez JA, Vader G, Span SW, Giaccone G and Medema RH. 2006. Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol Biol Cell 17:1897–1909.
   PubMed Web of Science ®Google Scholar
• Lentzsch S, Elliitt G and Roodman GD. 2007. SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating Hematologic malignancies including myeloma. Arch Pharm 340:511–516.
   PubMed Web of Science ®Google Scholar
• Li F. 2005. Role of survivin and its splice variants in tumorigenesis. Brit J Cancer 92:212–216.
   PubMed Web of Science ®Google Scholar
• Li FZ and Ling XA. 2006. Survivin study: An update of “What is the next wave?”. J Cell Physiol 208:476–486.
   PubMed Web of Science ®Google Scholar
• Li FZ, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584.
   PubMed Web of Science ®Google Scholar
• Li FZ, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC. 1999. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Biol 1:461–466.
   PubMed Web of Science ®Google Scholar
• Li FZ, Yang J, Ramnath N, Javle MM and Tan DF. 2005. Nuclear or cytoplasmic expression of survivin: What is the significance? Int J Cancer 114:509–512.
   PubMed Web of Science ®Google Scholar
• Li H, Chen Y, Jones AF, Sanger RH, Collis LP, Flannery R, McNay EC, Yu TX, Schwarzenbacher R, Bossy B, Bossy-Wetzel E, Bennett MVL, Pypaert M, Hickman JA, Smith PJS, Hardwick JM and Jonas EA. 2008. Bcl-X-L induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci USA 105:2169–2174.
   PubMedGoogle Scholar
• Li LY, Luo L and Wang XD. 2001. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95–99.
   PubMed Web of Science ®Google Scholar
• Li M, Ona VO, Chen M, Kaul M, Tenneti L, Zhang X, Stieg PE, Lipton SA and Friedlander RM. 2000. Functional role and therapeutic implications of neuronal caspase-1 and-3 in a mouse model of traumatic spinal cord injury. Neuroscience 99:333–342.
   PubMed Web of Science ®Google Scholar
• Li TF, Lu CZ, Xia ZL, Xiao BG and Luo YM. 2006. Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome c-dependent and Smac/DIABLO-independent way. Brain Res 1098:204–211.
   PubMedGoogle Scholar
• Li XN, Shu Q, Su JM, Adesina AM, Wong KK, Perlaky L, Antalffy BA, Blaney SM and Lau CC. 2007. Differential expression of survivin splice isoforms in medulloblastomas. Neuropathol Appl Neurobiol 33:67–76.
   PubMedGoogle Scholar
• Lin TS, Ruppert AS, Johnson AJ, Fischer B, Heerema NA, Andritsos LA, Blum KA, Flynn JM, Jones JA, Hu WH, Moran ME, Mitchell SM, Smith LL, Wagner AJ, Raymond CA, Schaaf LJ, Phelps MA, Villalona-Calero MA, Grever MR and Byrd JC. 2009. Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease. J Clin Oncol 27:6012–6018.
   PubMed Web of Science ®Google Scholar
• Lippert BM, Knauer SK, Fetz V, Mann W and Stauber RH. 2007. Dynamic survivin in head and neck cancer: Molecular mechanism and therapeutic potential. Int J Cancer 121:1169–1174.
   PubMed Web of Science ®Google Scholar
• Liste I, Garcia-Garcia E, Bueno C and Martinez-Serrano A. 2007. Bcl-X-L modulates the differentiation of immortalized human neural stem cells. Cell Death Differ 14:1880–1892.
   PubMedGoogle Scholar
• Liu YWJ, Mee EW, Bergin P, Teoh HH, Connor B, Dragunow M and Faull RLM. 2007. Adult neurogenesis in mesial temporal lobe epilepsy: A review of recent animal and human studies. Curr Pharmaceut Biotechnol 8:187–194.
   PubMedGoogle Scholar
• Loeffler M, Daugas E, Susin SA, Zamzami N, Metivier D, Nieminen AL, Brothers G, Penninger JM and Kroemer G. 2001. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. Faseb J 15:758–767.
   PubMed Web of Science ®Google Scholar
• Lopez RA, Goodman AB, Rhodes M, Blomberg JAL and Heller J. 2007. The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration. Anti-Cancer Drugs 18:933–939.
   PubMedGoogle Scholar
• Lordan S, Mackrill JJ and O’Brien NM. 2009. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J Nutrit Biochem 20:321–336.
   PubMed Web of Science ®Google Scholar
• Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE and Gerharz CD. 2002. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9:1334–1342.
   PubMed Web of Science ®Google Scholar
• Makrantoni V and Stark MJR. 2009. Efficient chromosome biorientation and the tension checkpoint in Saccharomyces cerevisiae both require Bir1. Mol Cell Biol 29:4552–4562.
   PubMedGoogle Scholar
• Mantoan L, Stefanova N, Egger KE, Jellinger KA, Poewe W and Wenning GK. 2005. Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy). Acta Neuropath 109:191–197.
   PubMedGoogle Scholar
• Marambaud P, Dreses-Werringloer U and Vingtdeux V. 2009. Calcium signaling in neurodegeneration. Mol Neurodegen 4:20.
   Google Scholar
• Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JPR and Melendez-Zajgla J. 2008. Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res 27:8.
   Google Scholar
• Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I and Reed JC. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22:2729–2740.
   PubMed Web of Science ®Google Scholar
• McLaughlin CT, Kane AG and Auber AE. 2003. MR imaging of heat stroke: external capsule and thalamic T1 shortening and cerebellar injury. Am J Neuroradiol 24:1372–1375.
   PubMed Web of Science ®Google Scholar
• McShea A, Harris PLR, Webster KR, Wahl AF and Smith MA. 1997. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease. Am J Pathol 150:1933–1939.
   PubMed Web of Science ®Google Scholar
• Minematsu T, Iwai M, Sugimoto K, Shirai N, Nakahara T, Usui T and Kamimura H. 2009. Carrier-mediated uptake of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro -1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small-molecule survivin suppressant, into human solid tumor and lymphoma cells. Drug Metab Dispos 37:619–628.
   PubMed Web of Science ®Google Scholar
• Minematsu T, Iwai M, Umehara K-I Usui, T and Kamimura H. 2010. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro -1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant. Drug Metab Dispos 38:1–4.
   PubMed Web of Science ®Google Scholar
• Miyata T, Kawaguchi D, Kawaguchi A and Gotoh Y. 2010. Mechanisms that regulate the number of neurons during mouse neocortical development. Curr Opin Neurobiol 20:22–28.
   PubMedGoogle Scholar
• Monteghirfo S, Tosetti F, Ambrosini C, Stigliani S, Pozzi S, Frassoni F, Fassina G, Soverini S, Albini A and Ferrari N. 2008. Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappa B and p53 modulation. Mol Cancer Therapeut 7:2692–2702.
   PubMed Web of Science ®Google Scholar
• Muchmore SW, Chen J, Jakob C, Zakula D, Matayoshi ED, Wu W, Zhang HC, Li FZ, Ng SC and Altieri DC. 2000. Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol Cell 6:173–182.
   PubMedGoogle Scholar
• Nabilsi NH, Broaddus RR and Loose DS. 2009. DNA methylation inhibits p53-mediated survivin repression. Oncogene 28:2046–2050.
   Google Scholar
• Nagy Z, Esiri MM, Cato AM and Smith AD. 1997. Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropath 94:6–15.
   PubMedGoogle Scholar
• Nandi S, Ulasov IV, Tyler MA, Sugihara AQ, Molinero L, Han Y, Zhu ZB and Lesniak MS. 2008. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res 68:5778–5784.
   PubMed Web of Science ®Google Scholar
• Nieto-Rementeria N, Perez-Yarza G, Boyano MD, Apraiz A, Izu R, Diaz-Perez JL and Asumendi A. 2009. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Brit J Dermatol 160:519–526.
   PubMed Web of Science ®Google Scholar
• Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, Van Bel F and Kavelaars A. 2008. A dual role of the NF-kappa B pathway in neonatal hypoxic-ischemic brain damage. Stroke 39:2578–2586.
   PubMed Web of Science ®Google Scholar
• Noton EA, Colnaghi R, Tate S, Starck C, Carvalho A, Ferrigno PK and Wheatley SP. 2006. Molecular analysis of survivin isoforms – evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem 281:1286–1295.
   PubMed Web of Science ®Google Scholar
• O’Connor DS, Grossman D, Plescia J, Li FZ, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC. 2000. Regulation of apoptosis at cell division by p34(cdc2) phosphorylation of survivin. Proc Natl Acad Sci USA 97:13103–13107.
   PubMed Web of Science ®Google Scholar
• Okada Y, Sakai H, Kohiki E, Suga E, Yanagisawa Y, Tanaka K, Hadano S, Osuga H and Ikeda JE. 2005. A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J Cereb Blood Flow Metab 25:794–806.
   PubMed Web of Science ®Google Scholar
• Okamoto J, Mikami I, Tominaga Y, Kuchenbecker KM, Lin YC, Bravo DT, Clement G, Yagui-Beltran A, Ray MR, Koizumi K, He BA and Jablons DM. 2008. Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma. J Thorac Oncol 3:1089–1095.
   PubMed Web of Science ®Google Scholar
• Ona VO, Li MW, Vonsattel JPG, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE, Yuan JY, Penney JB, Young AB, Cha JHJ and Friedlander RM. 1999. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease. Nature 399:263–267.
   PubMed Web of Science ®Google Scholar
• Parrish J, Li LL, Klotz K, Ledwich D, Wang XD and Xue D. 2001. Mitochondrial endonuclease G is important for apoptosis in C-elegans. Nature 412:90–94.
   PubMed Web of Science ®Google Scholar
• Pekarsky Y, Garrison PN, Palamarchuk A, Zanesi N, Aqeilan RI, Huebner K, Barnes LD and Croce CM. 2004. Fhit is a physiological target of the protein kinase Src. Proc Natl Acad Sci USA 101:3775–3779.
   PubMedGoogle Scholar
• Pennati M, Folini M and Zaffaroni N. 2007. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 28:1133–1139.
   PubMed Web of Science ®Google Scholar
• Perrelet D, Ferri A, Mackenzie AE, Smith GM, Korneluk RG, Liston P, Sagot Y, Terrado J, Monnier D and Kato AC. 2000. IAP family proteins delay motoneuron cell death in vivo. Eur J Neurosci 12:2059–2067.
   PubMedGoogle Scholar
• Perrelet D, Ferri A, Liston P, Muzzin P, Korneluk RG and Kato AC. 2002. IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nature Cell Biol 4:175–179.
   PubMed Web of Science ®Google Scholar
• Proskuryakov SY, Konoplyannikov AG and Gabai VL. 2003. Necrosis: a specific form of programmed cell death? Exp Cell Res 283:1–16.
   PubMed Web of Science ®Google Scholar
• Pumiglia KM and Decker SJ. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448–452.
   PubMed Web of Science ®Google Scholar
• Rami A, Bechmann I and Stehle JH. 2008. Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog Neurobiol 85:273–296.
   PubMed Web of Science ®Google Scholar
• Ray SK, Karmakar S, Nowak MW and Banik NL. 2006. Inhibition of calpain and caspase-3 prevented apoptosis and preserved electrophysiological properties of voltage-gated and ligand-gated ion channels in rat primary cortical neurons exposed to glutamate. Neuroscience 139:577–595.
   PubMedGoogle Scholar
• Renwick J, Narang MA, Coupland SG, Xuan JY, Baker AN, Brousseau J, Petrin D, Munger R, Leonard BC, Hauswirth WW, Korneluk RG and Tsilfidis C. 2006. XIAP-mediated neuroprotection in retinal ischemia. Gene Ther 13:339–347.
   PubMed Web of Science ®Google Scholar
• Rodel F, Muller B, Sieber R, Leumann W, Sauer R and Rodel C. 2006. Increase of the apoptosis rate and radiation-sensitisation of colorectal cancer cells through an antisense-oligonucleotide (Lilly LY2181308)-mediated inhibition of survivin. Strahlenther Onkol 182:90–90.
   Google Scholar
• Roovers K and Assoian RK. 2000. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22:818–826.
   PubMed Web of Science ®Google Scholar
• Rosa J, Canovas P, Islam A, Altieri DC and Doxsey SJ. 2006. Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell 17:1483–1493.
   PubMed Web of Science ®Google Scholar
• Ruchaud S, Carmena M and Earnshaw WC. 2007. The chromosomal passenger complex: One for all and all for one. Cell 131:230–231.
   PubMedGoogle Scholar
• Russell JC, Whiting H, Szuflita N and Hossain MA. 2008. Nuclear translocation of X-linked inhibitor of apoptosis (XIAP) determines cell fate after hypoxia ischemia in neonatal brain. J Neurochem 106:1357–1370.
   PubMed Web of Science ®Google Scholar
• Ryan BM, O’Donovan N and Duffy MJ. 2009. Survivin: A new target for anti-cancer therapy. Cancer Treat Rev 35:553–562.
   PubMed Web of Science ®Google Scholar
• Saitoh T, Igura M, Obita T, Ose T, Kojima R, Maenaka K, Endo T and Kohda D. 2007. Tom20 recognizes mitochondrial presequences through dynamic equilibrium among multiple bound states. EMBO J 26:4777–4787.
   PubMedGoogle Scholar
• Salomoni P and Calegari F. 2010. Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol 20:233–243.
   PubMed Web of Science ®Google Scholar
• Salvesen GS and Duckett CS. 2002. IAP proteins: Blocking the road to death’s door. Nature Rev Mol Cell Biol 3:401–410.
   PubMed Web of Science ®Google Scholar
• Sampath JLMP. 2007. Alternative splice variants of survivin as potential targets in cancer. Current Drug Discov Technol 4:19.
   Google Scholar
• Samuel T, Okada K, Hyer M, Welsh K, Zapata JM and Reed JC. 2005. clAP1 localizes to the nuclear compartment and modulates the cell cycle. Cancer Res 65:210–218.
   PubMedGoogle Scholar
• Satoh T, Okamoto I, Miyazaki M, Morinaga R, Tsuya A, Hasegawa Y, Terashima M, Ueda S, Fukuoka M, Ariyoshi Y, Saito T, Masuda N, Watanabe H, Taguchi T, Kakihara T, Aoyama Y, Hashimoto Y and Nakagawa K. 2009. Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res 15:3872–3880.
   PubMed Web of Science ®Google Scholar
• Semba S, Trapasso F, Fabbri M, McCorkell KA, Volinia S, Druck T, Iliopoulos D, Pekarsky Y, Ishii H, Garrison PN, Barnes LD, Croce CM and Huebner K. 2006. Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential. Oncogene 25:2860–2872.
   PubMed Web of Science ®Google Scholar
• Shen CX, Liu WJ, Buck AK and Reske SN. 2009. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells. Anticancer Res 29:1423–1428.
   PubMedGoogle Scholar
• Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y. 2004. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nature Cell Biol 6:1221–1228.
   PubMed Web of Science ®Google Scholar
• Shioi G, Konno D, Shitamukai A and Matsuzaki F. 2009. Structural basis for self-renewal of neural progenitors in cortical neurogenesis. Cereb Cortex 19:I55–I61.
   PubMedGoogle Scholar
• Shishodia S and Aggarwal BB. 2002. Nuclear factor-kappa B activation: A question of life or death. J Biochem Mol Biol 35:28–40.
   PubMedGoogle Scholar
• Si Z-H, Zhang X-Q, Tang J-Y. 2009. Effects of electric stimulation treatment on motor function and expression of microtubule-associated protein-2 and survivin of brain tissue in cerebral infarction rats J Clin Neurol 22:4.
   Google Scholar
• Skoufias DA, Mollinari C, Lacroix FB and Margolis RL. 2000. Human survivin is a kinetochore-associated passenger protein. J Cell Biol 151:1575–1581.
   PubMed Web of Science ®Google Scholar
• Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ. 1999. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281–292.
   PubMed Web of Science ®Google Scholar
• Smale G, Nichols NR, Brady DR, Finch CE and Horton WE. 1995. Evidence for apoptotic cell-death in Alzheimers-disease. Exp Neurol 133:225–230.
   PubMed Web of Science ®Google Scholar
• Smith MZ, Nagy Z and Esiri MM. 1999. Cell cycle-related protein expression in vascular dementia and Alzheimer’s disease. Neurosci Lett 271:45–48.
   PubMed Web of Science ®Google Scholar
• Song ZY and Wu M. 2005. Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation. Oncogene 24:2723–2734.
   PubMedGoogle Scholar
• Song ZY, Liu SX, He H, Hoti N, Wang Y, Feng SS and Wu M. 2004. A single amino acid change (Asp 53 –> Ala53) converts survivin from anti-apoptotic to pro-apoptotic. Mol Biol Cell 15:1287–1296.
   PubMed Web of Science ®Google Scholar
• Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang ZW and Alnemri ES. 2000. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 275:36152–36157.
   PubMed Web of Science ®Google Scholar
• Stauber RH, Mann W and Knauer SK. 2007. Nuclear and cytoplasmic survivin: Molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67:5999–6002.
   PubMed Web of Science ®Google Scholar
• Sun CH, Nettesheim D, Liu ZH and Olejniczak ET. 2005. Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 44:11–17.
   PubMed Web of Science ®Google Scholar
• Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC and Kroemer G. 2000. Two distinct pathways leading to nuclear apoptosis. J Exp Med 192:571–579.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sozen T, Hasegawa Y, Chen WQ and Zhang JH. 2009. Caspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in mice. Stroke 40:3872–3875.
   PubMedGoogle Scholar
• Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M and Reed JC. 2000. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6:1796–1803.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Igarashi S, Nakamura M, Gafni J, Torcassi C, Schilling G, Crippen D, Wood JD, Sawa A, Jenkins NA, Copeland NG, Borchelt DR, Ross CA and Ellerby LM. 2006. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiol Dis 21:381–391.
   PubMedGoogle Scholar
• Teles AVF, Ureshino RP, Dorta DJ, Lopes GS, Hsu YT and Smaili SS. 2008. Bcl-X-L inhibits Bax-induced alterations in mitochondrial respiration and calcium release. Neurosci Lett 442:96–99.
   PubMedGoogle Scholar
• Timmer T, De Vries EGE and De Jong S. 2002. Fas receptor-mediated apoptosis: a clinical application? J Pathol 196:125–134.
   PubMed Web of Science ®Google Scholar
• Tolosa L, Mir M, Asensio VJ, Olmos G and Llado J. 2008. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem 105:1080–1090.
   PubMedGoogle Scholar
• Trapp T, Korhonen L, Besselmann M, Martinez R, Mercer EA and Lindholm D. 2003. Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol Cell Neurosci 23:302–313.
   PubMedGoogle Scholar
• Troost D, Aten J, Morsink F and Dejong J. 1995. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 21:498–504.
   PubMed Web of Science ®Google Scholar
• Tsuji N, Asanuma K, Kobayashi D, Yagihashi A and Watanabe N. 2005. Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells. Anticancer Res 25:3967–3972.
   PubMedGoogle Scholar
• Tsuruma T, Iwayama Y, Ohmura T, Katsuramaki T, Hata F, Furuhata T, Yamaguchi K, Kimura Y, Torigoe T, Toyota N, Yagihashi A, Hirohashi Y, Asanuma H, Shimozawa K, Okazaki M, Mizushima Y, Nomura N, Sato N and Hirata K. 2008. Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer. J Translat Med 6:24.
   Google Scholar
• Usmani SZ, Bona R and Li ZH. 2009. 17 AAG for HSP90 Inhibition in cancer – from bench to bedside. Curr Mol Med 9:654–664.
   PubMed Web of Science ®Google Scholar
• Vaira V, Lee CW, Goel HL, Bosari S, Languino LR and Altieri DC. 2007. Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 26:2678–2684.
   PubMed Web of Science ®Google Scholar
• Vanoosthuyse V and Hardwick KG. 2009. Overcoming inhibition in the spindle checkpoint. Genes Dev 23:2799–2805.
   Google Scholar
• Villapol S, Acarin L, Faiz M, Castellano B and Gonzalez B. 2008. Survivin and heat shock protein 25/27 colocalize with cleaved caspase-3 in surviving reactive astrocytes following excitotoxicity to the immature brain. Neuroscience 153:108–119.
   PubMed Web of Science ®Google Scholar
• Vong QP, Cao K, Li HY, Iglesias PA and Zheng YX. 2005. Chromosome alignment and segregation regulated by ubiquitination of survivin. Science 310:1499–1504.
   PubMed Web of Science ®Google Scholar
• Vucic D and Fairbrother WJ. 2007. The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 13:5995–6000.
   PubMed Web of Science ®Google Scholar
• Wang CX and Youle RJ. 2009. The role of mitochondria in apoptosis. Ann Rev Genet 43:95–118.
   PubMed Web of Science ®Google Scholar
• Wang J and Lenardo MJ. 2000. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 113:753–757.
   PubMed Web of Science ®Google Scholar
• Wang R, Lin F, Wang X, Gao P, Dong K, Wei SH, Cheng SY and Zhang HZ. 2007. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression. Cancer Biol Ther 6:1295–1301.
   PubMed Web of Science ®Google Scholar
• Wang XY, Zhu CL, Wang XH, Hagberg H, Korhonen L, Sandberg M, Lindholm D and Blomgren K. 2004. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol Dis 16:179–189.
   PubMedGoogle Scholar
• Weis K. 2003. Regulating access to the genome: Nucleocytoplasmic transport throughout the cell cycle. Cell 112:441–451.
   PubMed Web of Science ®Google Scholar
• West AB, Dawson VL and Dawson TM. 2005. To die or grow: Parkinson’s disease and cancer. Trends Neurosci 28:348–352.
   PubMed Web of Science ®Google Scholar
• Wheatley SP, Henzing AJ, Dodson H, Khaled W and Earnshaw WC. 2004. Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J Biol Chem 279:5655–5660.
   PubMed Web of Science ®Google Scholar
• Wojda U, Salinska E and Kuznicki J. 2008. Calcium ions in neuronal degeneration. Iubmb Life 60:575–590.
   PubMed Web of Science ®Google Scholar
• Wootz H, Hansson I, Korhonen L and Lindholm D. 2006. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 312:1890–1898.
   PubMed Web of Science ®Google Scholar
• Wu B, Ma Q, Khatibi N, Chen W, Sozen T, Cheng O and Tang J 2010. Ac-YVAD-CMK decreases blood-brain barrier degradation by inhibiting caspase-1 activation of interleukin-1β in intracerebral hemorrhage mouse model. Translat Stroke Res 1:57–64.
   PubMedGoogle Scholar
• Wu X, Tian F, Okagaki P and Marini AM. 2005. Inhibition of N-methyl-D-aspartate receptors increases paraoxon-induced apoptosis in cultured neurons. Toxicol Appl Pharmacol 208:57–67.
   PubMed Web of Science ®Google Scholar
• Xia F, Canovas PM, Guadagno TM and Altieri DC. 2008. A survivin-Ran complex regulates spindle formation in tumor cells. Mol Cell Biol 28:5299–5311.
   PubMed Web of Science ®Google Scholar
• Xu DG, Crocker SJ, Doucet JP, Stjean M, Tamai K, Hakim AM and Ikeda JE. 1997. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 3:997–1004.
   PubMed Web of Science ®Google Scholar
• Yan H, Thomas J, Liu T, Raj D, London N, Tandeski T, Leachman SA, Lee RM and Grossman D. 2006. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable survivin antagonist. Oncogene 25:6968–6974.
   PubMedGoogle Scholar
• Yang Y and Herrup K. 2005. Loss of neuronal cell cycle control in ataxia-telangiectasia: A unified disease mechanism. J Neurosci 25:2522–2529.
   PubMed Web of Science ®Google Scholar
• Yang Y, Geldmacher DS and Herrup K. 2001. DNA replication precedes neuronal cell death in Alzheimer’s disease. J Neurosci 21:2661–2668.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang L, Wang HM, Shang XY, Niu W, Li JT and Wu YZ. 2008. A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency. Mol Immunol 45:1674–1681.
   Google Scholar
• Yin W, Cao GD, Johnnides MJ, Signore AP, Luo YM, Hickey RW and Chen J. 2006. TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol Dis 21:358–371.
   PubMedGoogle Scholar
• Zhang QG, Wang RM, Khan M, Mahesh V and Brann DW. 2008. Role of dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci 28:8430–8441.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang T, Li KN, Qin WW, Chen R, Wang K, Jia LT, Zhao J, Wen WH, Meng YL, Yao LB and Yang AG. 2008. A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells. Cancer Biol Ther 7:547–554.
   PubMed Web of Science ®Google Scholar
• Zhang R, Xue YY, Lu SD, Wang Y, Zhang LM, Huang YL, Signore AP, Chen J and Sun FY. 2006. Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiol Dis 24:345–356.
   PubMedGoogle Scholar
• Zhang YH, Park TS and Gidday JN. 2007. Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol – Heart Circul Physiol, 292:H2573–H2581.
   Google Scholar
• Zhu DE, Hoti N, Song Z, Jin L, Wu Z, Wu Q and Wu M. 2006. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model. Cancer Gene Ther 13:762–770.
   PubMedGoogle Scholar